Sanofi breaks into digital therapeutics with mental health app for MS patients

"Sanofi joins the digital therapeutics market Tuesday with a proposed app to improve mental health in patients with multiple sclerosis. Created in partnership with established mental health digital therapeutics firm Happify Health, the app is currently in a proof-of-concept online trial with several thousand MS patients. After those results, expected later this year, are in, Sanofi and Happify plan to submit the app to the FDA to go through the..." Lire la suite